Cell-Free DNA: Features and Attributes Shaping the Next Frontier in Liquid Biopsy.

Area of Science:

• Biochemistry
• Molecular Biology
• Genomics

Background:

• Cell-free DNA (cfDNA) is a key component of liquid biopsies, utilized in oncology, prenatal testing, and transplant monitoring.
• The biogenesis, fragmentation, and clearance of cfDNA are intricate processes influencing its biomarker potential.
• Emerging cfDNA fragmentomics leverages non-mutational signatures like fragment size and methylation for advanced diagnostics.

Purpose of the Study:

• To review the structural diversity of cfDNA, focusing on various fragment sizes.
• To discuss the distinct biological origins and clinical utility of different cfDNA subsets.
• To highlight the advancements in sequencing methodologies and their impact on cfDNA applications.

Main Methods:

• Review of existing literature on cfDNA biogenesis, fragmentation, and clearance.
• Analysis of structural diversity in cfDNA fragments based on size.
• Examination of different methodologies for cfDNA detection and analysis in biofluids.

Main Results:

• cfDNA fragment size and structural diversity are influenced by cell death and DNA repair mechanisms.
• Different cfDNA subsets offer insights into genomic and epigenetic features, gene regulation, and disease progression.
• Advanced sequencing techniques enable the identification of specific cfDNA subsets for diagnostic and therapeutic purposes.

Conclusions:

• cfDNA fragmentomics presents a promising avenue for advancing liquid biopsy diagnostics.
• Understanding cfDNA subsets enhances insights into tissue-specific functions and disease mechanisms.
• Continued research into cfDNA is crucial for its integration into routine clinical practice and personalized medicine.